Cancer
Minority groups underrepresented in hematologic cancer trials
Minority groups underrepresented in hematologic cancer trials
Source link
A qualitative study identifying challenges resulting from complex evidence on lifestyle factors and cancer: perspectives from Black and Latina canc...
Purpose:
Most breast cancer survivors have challenges with adopting healthy lifestyle behaviors. This may be due to contextual chall...
Determinants of Lung Cancer Screening in a Minnesota Urban Indigenous Community - A Community Based, Participatory, Action-Oriented Study
Although lung cancer screening with annual low-dose chest computed tomography has been shown to reduce lung cancer deaths, it remains underutilized...
Oncologist serves the underserved; liquid biopsies in cancer care
January 05, 2023
1 min read
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on
Please provide your e...
Only 1 of 25 cancer drug developers fairly included minority patients over five-year window, BMJ analysis finds
New clinical trial diversity plans, which FDA will soon explain further, were featured in the government spending package that President Joe Biden ...
Neighborhood segregation and cancer prevention guideline adherence in US Hispanic/Latino adults: Results from the HCHS/SOL
Background:
Adherence to the American Cancer Society (ACS) guidelines for cancer prevention is associated with a lower risk of cance...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
